FRANKFORT, IL / ACCESSWIRE / November 17, 2024 / Hometown NP, co-founded by Dr. Chime Ajiere, DNP, in 2023, is…
Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen Uptake Recovery and Quality of Life New Data…
HateEraser removes hate-based graffiti in communities and gives first-time offenders a second chance through judge-mandated service NEW YORK, Nov. 16,…
Boston Female Leaders Support Whittier Street Health Center's Vulnerable and Underserved Women and FamiliesBOSTON, MA / ACCESSWIRE / November 16,…
SHANGHAI, Nov. 16, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
– Investor & analyst webcast, including a key opinion leader panel, to be held Monday, November 18th at 7:30 a.m.…
Data will be presented on Monday, November 18th as a late breaker poster at the American Association for the Study…
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use…
Weekly subcutaneous doses of pemvidutide resulted in robust reductions in cardio-inflammatory, hepato-inflammatory and atherosclerotic lipids Findings support the potential benefit…
The amivantamab plus lazertinib combination regimen offers potential to provide new standard of care as first-line option for adult patients…